NETS

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results

Retrieved on: 
Thursday, March 28, 2024

SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today provided a business update and announced fiscal year 2023 financial results for the period ended December 31, 2023.

Key Points: 
  • SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today provided a business update and announced fiscal year 2023 financial results for the period ended December 31, 2023.
  • “We made tremendous progress during 2023 in building a fully integrated radiopharmaceuticals company dedicated to advancing potentially best- or first-in-class alpha-particle therapies,” said Thijs Spoor, Perspective Therapeutics' CEO.
  • Preliminary results from Cohorts 1 and 2 of the Phase 1/2a trial are expected in the third quarter 2024.
  • In January 2024, Perspective Therapeutics entered into strategic agreements with Lantheus Holdings, Inc. and its affiliates (“Lantheus”) (NASDAQ: LNTH).

Star Leasing Company, Commercial Trailer Leasing, Inc., Cooling Concepts, and North East Trailer Services Leasing Announce Intent to Change Name to TEN (Transportation Equipment Network)

Retrieved on: 
Friday, April 5, 2024

Star Leasing Company, CTL (Commercial Trailer Leasing, Inc.), Cooling Concepts, and NETS Leasing (North East Trailer Services), portfolio companies of I Squared Capital, announced today their intent to rebrand and change their name to TEN (Transportation Equipment Network).

Key Points: 
  • Star Leasing Company, CTL (Commercial Trailer Leasing, Inc.), Cooling Concepts, and NETS Leasing (North East Trailer Services), portfolio companies of I Squared Capital, announced today their intent to rebrand and change their name to TEN (Transportation Equipment Network).
  • View the full release here: https://www.businesswire.com/news/home/20240405724373/en/
    TEN offers full-service trailer solutions that keep businesses moving forward.
  • We are excited about the future and our combined ability to provide employees, customers, and suppliers with a platform unlike any other.
  • This is truly just the beginning of our journey to build a completely unique company,” said Scott Nelson, President.

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

Retrieved on: 
Monday, March 25, 2024

HENDERSON, Nev., March 25, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced financial results and a business update for the full fiscal year ended December 31, 2023. Volition management will host a conference call tomorrow, March 26 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below.

Key Points: 
  • Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30 a.m. U.S. Eastern Time
    HENDERSON, Nev., March 25, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced financial results and a business update for the full fiscal year ended December 31, 2023.
  • Volition management will host a conference call tomorrow, March 26 at 8:30 a.m. U.S. Eastern Time to discuss these results.
  • Cameron Reynolds, President and Group Chief Executive Officer of Volition said: "2023 was certainly transformational for Volition and a year we can look back on with pride.
  • Cash and cash equivalents as of December 31, 2023, totaled approximately $20.7 million as compared to $10.9 million as of December 31, 2022.

Volition appoints Dr Andrew Retter as Chief Medical Officer

Retrieved on: 
Tuesday, March 19, 2024

HENDERSON, Nev., March 19, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Dr Andrew Retter as its Chief Medical Officer, effective April 1, 2024.

Key Points: 
  • HENDERSON, Nev., March 19, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Dr Andrew Retter as its Chief Medical Officer, effective April 1, 2024.
  • Dr Retter will provide medical leadership at Volition and ensure the company's scientific and clinical efforts are aligned with patient needs.
  • Cameron Reynolds, President and Group Chief Executive Officer at Volition, said: "We are delighted to welcome Andrew to Volition.
  • As Chief Medical Officer he will be vital to our success – ensuring the needs of the patient are placed at the heart of our research, development and commercialization activities."

Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results

Retrieved on: 
Tuesday, March 5, 2024

REHOVOT, Israel, March 05, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • REHOVOT, Israel, March 05, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the fourth quarter and full year ended December 31, 2023.
  • At the American Association for Cancer Research (AACR) Special Conference on pancreatic cancer, Purple Biotech presented new potential PDAC biomarker data for CM24.
  • In February 2023, Purple Biotech acquired a platform of conditionally activated T cell and NK cell engagers that selectively activate immune response within the tumor microenvironment.
  • As of December 31, 2023, Purple Biotech had cash and cash equivalents and short-term deposits of $15.3 million, compared to $31.7 million on December 31, 2022.

Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award

Retrieved on: 
Wednesday, February 28, 2024

NEW YORK, Feb. 28, 2024 /PRNewswire/ -- The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award (LMTA), whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus (SLE).

Key Points: 
  • NEW YORK, Feb. 28, 2024 /PRNewswire/ -- The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award (LMTA), whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus (SLE).
  • The development of targeted treatments is hindered by an incomplete understanding of lupus and its devastating complications.
  • These seven talented investigators will identify targets for new treatments and test novel therapeutic avenues to revolutionize the field and improve the lives of individuals with lupus.
  • Surgical biopsies of the kidneys are often needed to diagnose lupus nephritis (LN), kidney inflammation caused by lupus that can result in severe and sometimes life-threatening organ damage.

Should Taylor Swift be taught alongside Shakespeare? A professor of literature says yes

Retrieved on: 
Thursday, February 15, 2024

It’s 2024 and he was born in 1564, and she’s only 34.

Key Points: 
  • It’s 2024 and he was born in 1564, and she’s only 34.
  • Sliding her into the classroom would be yet another example of a dumbed-down curriculum.
  • Well, the dates might be, but not the assumptions – about Shakespeare, about English, about teaching, and about Swift.
  • In Sweet Nothing, on the Midnights album, she sings:
    On the way home
    I wrote a poem
    You say “What a mind”
    This happens all the time.
  • Read more:
    How did Taylor Swift get so popular?

An ally of literature

  • Regardless of what The Tortured Poets Department ends up being about, Swift is already a firm ally of literature and reading.
  • It’s that the discipline of English literature is flexible, capacious and open-minded.
  • A class on reading Swift’s work as literature is just another English class, because every English class requires grappling with the idea of reading anything as literature.
  • A class on reading Swift’s work as literature is just another English class, because every English class requires grappling with the idea of reading anything as literature.
  • I will be teaching Midnights and Shakespeare’s Sonnets together in a literature unit at the University of Sydney this semester.

Teaching Midnights and Shakespeare’s Sonnets

  • I also teach three modern artworks that shed contemporary light on the sonnets.
  • Bervin prints a selection of the sonnets, one per page, in grey text.
  • In each of these grey sonnets, some of Shakespeare’s words and phrases are printed in black and thus stand out boldly.
  • Unlike Bervin’s and Kennard’s collections, in which individual pieces relate to specific sonnets, there is no explicit adaptation.

Deep connection

  • The fun challenge of writing a pop song is squeezing those evocative details into the catchiest melody you can possibly think of.
  • I thrive on the challenge of sprinkling personal mementos and shreds of reality into a genre of music that is universally known for being, well, universal.
  • Her point is that the pop songs that “cut through the most are actually the most detailed” in their snippets of reality and biography.
  • She says “people are reaching out for connection and comfort” and “music lovers want some biographical glimpse into the world of our narrator, a hole in the emotional walls people put up around themselves to survive”.
  • Swift claims that Midnights lets listeners in through her protective walls to enable deep connection:
    I really don’t think I’ve delved this far into my insecurities in this detail before.
  • This connects very well with the agenda of Midnights.
  • Swift’s songs and Shakespeare’s Sonnets are meditations on deeply personal aspects of their narrators’ experiences.
  • Swift’s persona is that of a self-reflective singer, just as Shakespeare’s is that of a self-reflective sonneteer.

Close reading


Shakespeare’s sonnets are rewarding texts for close reading because of their poetic intricacy. Students can look at end rhymes and internal rhymes, the way the argument progresses through quatrains, the positioning of the “turn”, which is often in line 9 or 13, and the way the final couplet wraps things up (or doesn’t).

  • Karma and Mastermind are simpler, yet contain plenty of metaphoric language to be unpacked for meaning and aesthetic effectiveness.
  • Such unexpected pairings are valuable because they require close attention and careful articulation of what is similar and what is not.
  • How about High Infidelity and Sonnet 138 (where love and self-deception coexist), considered in terms of truth in relationships?
  • There is nothing to lose and plenty to gain in teaching Swift’s Midnights and Shakespeare’s Sonnets together.


Liam E Semler receives research funding from the Better Strangers project which is a collaborative education research project between the University of Sydney and Barker College. Better Strangers hosts the Shakespeare Reloaded website (https://shakespearereloaded.edu.au/) and explores innovative approaches to teaching and learning Shakespeare.

Billy King Joins Global Talent Firm ZRG and TurnkeyZRG

Retrieved on: 
Monday, February 12, 2024

ROCHELLE PARK, N.J., Feb. 12, 2024 (GLOBE NEWSWIRE) -- ZRG , the global talent firm, and its TurnkeyZRG , sports, entertainment & media division, today announced its continued growth with the hire of Billy King as Managing Director in the Private Equity group and the Sports Group.

Key Points: 
  • ROCHELLE PARK, N.J., Feb. 12, 2024 (GLOBE NEWSWIRE) -- ZRG , the global talent firm, and its TurnkeyZRG , sports, entertainment & media division, today announced its continued growth with the hire of Billy King as Managing Director in the Private Equity group and the Sports Group.
  • Billy was Captain of the Duke basketball team in 1988 and was a part of the 1986 and 1988 Final Four teams.
  • Billy King at Duke, Billy King as a Coach, Billy King in the NBA, and Billy King in his personal journey has always had a knack for spotting talent, getting the most out of talent and creating winning teams with the exact right talent choices.
  • TurnkeyZRG is blessed to have Billy join our team,” said Len Perna, TurnkeyZRG’s Chairman and CEO.

Accellera Forms SystemVerilog Mixed-Signal Interface Types Working Group

Retrieved on: 
Wednesday, February 7, 2024

ELK GROVE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Accellera Systems Initiative (Accellera), the electronics industry organization focused on the creation and adoption of electronic design automation (EDA) and intellectual property (IP) standards, announced today the formation of the SystemVerilog Mixed-Signal Interface Types (SystemVerilog MSI) Working Group (WG).

Key Points: 
  • ELK GROVE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Accellera Systems Initiative (Accellera), the electronics industry organization focused on the creation and adoption of electronic design automation (EDA) and intellectual property (IP) standards, announced today the formation of the SystemVerilog Mixed-Signal Interface Types (SystemVerilog MSI) Working Group (WG).
  • The scope of the new working group is to document a SystemVerilog-compatible language extension to permit interconnect, conversion, and resolution among dissimilar net types in SystemVerilog, including bidirectional connections.
  • For more information on the SystemVerilog MSI Working group, visit the working group page .
  • If you are not already an Accellera member and are interested in joining to participate in the working group and the ongoing development of the standard, visit here .

Lockton Joins The Network of Employers for Traffic Safety Board of Directors

Retrieved on: 
Monday, January 29, 2024

The Network of Employers for Traffic Safety (NETS) is pleased to announce that Lockton has joined the organization’s Board of Directors.

Key Points: 
  • The Network of Employers for Traffic Safety (NETS) is pleased to announce that Lockton has joined the organization’s Board of Directors.
  • Lockton is the world's largest independently held insurance broker helping clients strengthen their businesses through risk management, insurance, employee benefits consulting and retirement services solutions.
  • “The Board of Directors is thrilled to welcome Lockton Board representative Jay Gnadt, Senior Vice President, to NETS,” said Susan Hipp, NETS Executive Director.
  • They are senior level leaders who promote NETS’ mission and represent businesses and organizations that have created a proactive safety culture by promoting traffic safety policies and awareness activities in their workplaces.